Randomized phase 2 trial of NP001-a novel immune regulator:...

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS

Miller, R. G., Block, G., Katz, J. S., Barohn, R. J., Gopalakrishnan, V., Cudkowicz, M., Zhang, J. R., McGrath, M. S., Ludington, E., Appel, S. H., Azhir, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
Neurology: Neuroimmunology & Neuroinflammation
DOI:
10.1212/nxi.0000000000000100
Date:
April, 2015
File:
PDF, 754 KB
english, 2015
Conversion to is in progress
Conversion to is failed